Aktis Oncology Ownership & Insider Activity

Aktis Oncology (AKTS) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.4% of shares outstanding. Institutional investors hold 24.4%.

Shares Outstanding

55.619M

Shares Float

16.168M

Insider Shares Owned

236.566K

Insider % Owned

0.4%

Institutional Shares Held

13.573M

Institutional % Held

24.4%

Ownership Breakdown

Net Insider Activity by Month

Aktis Oncology Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 23, 2026	Akos Czibere	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$12.82	$197K
Jul 20, 2026	Ken Herrmann	—	SELL-OPTIONS	—	$12.58	$116K
Jul 17, 2026	Ken Herrmann	—	SELL-OPTIONS	—	$12.64	$77K
Jul 8, 2026	Shulamit RonBigger	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$15.71	$1.2M
Jul 8, 2026	Akos Czibere	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$16.36	$1.1M